SPCE

Virgin Galactic Holdings, Inc. - 10-Q Summary (Q2 2026)

Business Context and Reporting Period

This report covers the quarterly period ended June 30, 2026. Virgin Galactic is an aerospace company in the pre-commercial service phase, focused on developing next-generation spaceships to expand flight capacity. The company expects to commence flight testing in October 2026 and restart commercial service in February 2027. As of June 30, 2026, there were 141,277,897 shares of common stock outstanding.

Key Financial Metrics

Note: Revenue is minimal and primarily attributable to access fees for the astronaut community. The company has no spaceflight revenue as it remains in the pre-commercial phase.

Material Changes vs. Prior Period

• Revenue: Decreased to $134,000 for Q2 2026 from $406,000 in Q2 2025. Six-month revenue dropped to $361,000 from $867,000.
• Operating Expenses: Total operating expenses decreased to $65.1 million in Q2 2026 from $70.3 million in Q2 2025.
  • Spaceline Operations: Increased significantly to $28.2 million (from $14.2 million) due to the transition from development to manufacturing and testing of next-generation vehicles.
  • Research & Development: Decreased sharply to $4.3 million (from $20.1 million) as the development phase of next-generation vehicles was completed.
  • Selling, General & Administrative (SG&A): Decreased to $28.6 million (from $31.9 million), partly due to the absence of a $2.9 million legal settlement expense recorded in the prior year.
• Debt Restructuring: The company recognized an $8.6 million gain on extinguishment of debt in Q2 2026. This resulted from redeeming $40.5 million of 2028 Notes and exchanging $52.5 million of 2027 Notes for equity and pre-funded warrants.
• Liquidity: Cash and cash equivalents increased to $187.3 million from $144.7 million at year-end 2025, driven by financing activities.

Guidance, Outlook, and Risks

• Going Concern Warning: Management has concluded that there are conditions raising substantial doubt about the company's ability to continue as a going concern for the next twelve months. This determination was made excluding potential revenues, capital market transactions, and debt repayment term changes.
  • Mitigation Plans: Commencing commercial service in February 2027; collecting final payments from the backlog of ~675 astronauts (approx. $203 million expected revenue); selling premium-priced early flights; and raising additional capital via debt or equity (including the "at-the-market" program).
• Operational Outlook: Flight test program for next-generation spaceships expected to commence in October 2026. Commercial service restart targeted for February 2027.
• Legal Proceedings:
  • Lavin Class Action: Settled for $8.5 million (with $6.25 million expected from insurance). Payments made in April 2026; awaiting final court approval.
  • Derivative Litigation: Settlement in principle reached for $2.75 million (paid by insurers) to resolve consolidated derivative actions. Awaiting final court approval.
• Risks: Delays in commercial flights, safety issues, inability to convert backlog to revenue, and extensive regulatory requirements.

Investor Verification Checklist

• Going Concern Status: Verify the company's ability to secure additional financing or generate sufficient cash from the astronaut backlog to fund operations through the next 12 months.
• Debt Maturities: Confirm the repayment schedule for the remaining $17.9 million of 2027 Notes due in February 2027 and the $172.0 million of 2028 Notes.
• Commercial Timeline: Monitor progress on the October 2026 flight test program and the February 2027 commercial service restart.
• Legal Settlements: Track final court approvals for the Lavin and derivative litigation settlements to ensure no unexpected liabilities arise.
• Capital Raises: Review the utilization of the "at-the-market" (ATM) offering program, which generated $145 million in gross proceeds in the first half of 2026.